Vasculitis: all 231 studies
Page 3 of 3. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.
- Anti-Cytokine Therapy for VasculitisCompletedNCT00753103Phase 2
- Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesStatus unknownNCT00751517Phase 2
- Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
- Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis PatientsCompletedNCT00574652Phase 1/2
- Abatacept in ANCA Associated VasculitisTerminatedNCT00482066Phase 2
- Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated VasculitidesCompletedNCT00430105Phase 2/3
- Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA VasculitisCompletedNCT00414128Phase 2/3
- CellCept in p-ANCA VasculitisCompletedNCT00405860Phase 1
- WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated VasculitidesStatus unknownNCT00349674Phase 3
- The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory DiseaseCompletedNCT00331331
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
- Intravenous Immunoglobulin After Relapse in VasculitisTerminatedNCT00307658Phase 3
- IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic VasculitisTerminatedNCT00307645Phase 3
- MMF Versus CTX in the Induction Treatment of ANCA Associated VasculitisCompletedNCT00301652Not applicable
- Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and VasculitisCompletedNCT00293072Phase 2
- Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)CompletedNCT00167583Phase 3
- Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated VasculitisTerminatedNCT00128895Phase 4
- Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)CompletedNCT00103792Phase 3
- Biological Markers in Retinal VasculitisCompletedNCT00050492
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable
- Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel InflammationCompletedNCT00005928Phase 2
- Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis SyndromesCompletedNCT00004567Phase 2
- Absorption of Corticosteroids in Children With Juvenile DermatomyositisCompletedNCT00004357Phase 2
- Etanercept to Treat Wegener's GranulomatosisCompletedNCT00001901Phase 2
- Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory ConditionsCompletedNCT00001764Phase 1
- Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's GranulomatosisCompletedNCT00001761Phase 1
- Analysis of Bronchial Tissue and Fluid in Patients With Wegener's GranulomatosisCompletedNCT00001541
- Cyclophosphamide and Prednisone Followed by Methotrexate To Treat VasculitidesCompletedNCT00001473
- Steroids and Methotrexate to Treat Systemic VasculitisCompletedNCT00001256Phase 2
- Assessment of Patients With Multiple Sclerosis (MS)CompletedNCT00001156
- Treatment of Wegener's Granulomatosis With CyclophosphamideCompletedNCT00001155Phase 2